Biggest News Aggregation in the World
📰 Multiple News

Page 241 - Multiple News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Multiple. Real-time updates on events, politics, business and more.

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in A.G.P.'s Virtual Healthcare Conference

ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney... | May 11, 2023
Dave Schemelia Casey Mcdonald Stephenc Glover Zyversa Therapeutics Inc Securities Exchange Tiberend Strategic Advisors Inc

GBX International Group, Inc. Confirms 2023 Strong Revenue Growth Guidance Projections by Combining Each Acquired Operating Company Product Release, Expects Strong Growth Sector by Sector Through its Multiple Product Releases into North American and Inter

LOS ANGELES, CA / ACCESSWIRE / May 11, 2023 / GBX International Group, Inc., (OTC:GBXI) an emerging leader in international economic development, is pleased to confirm its 2023 projected revenue growth
United States Raymondc Dabney Scholarship Apprentice Program American States University American States University Digital Business American Association Of Advertising Agencies

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Rimini Street, Inc.: Rimini Street Honored by Clients and Industry with Multiple Service and Leadership Awards in Recognition of its Commitment to Delivering Extraordinary

Company receives accolades from clients in UK and Brazil, and colleague awarded with Female Executive of the Year distinction Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end
United States United Kingdom Michelle Davenport C Company Global Communications Exchange Commission

New Results from Phase 2 Trial Confirm Benefit of Trilaciclib in Reducing Adverse Events Related to an Antibody Drug Conjugate (ADC)

- On-Target Effect of Trilaciclib Reduces Rates of Multiple Adverse Events Associated with Sacituzumab Govitecan-Hziy by Over 50% Including Neutropenia, Anemia, and Diarrhea - - Most Enrolled... | May 10, 2023
United States Sacituzumab Govitecan Sacituzumab Govitecan Hziy Raj Malik Investor Relations Corporate Communications European Society For Medical Oncology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science